Head and neck cancer survivors patients and late effects related to oncologic treatment: Update of literature

R. Taibi, A. Lleshi, L. Barzan, F. Fiorica, M. Leghissa, E. Vaccher, P. De Paoli, G. Franchin, M. Berretta, U. Tirelli

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Cancer survivorship represents a new challenge in the third Millennium. In Europe the number of cancer survivors was estimated to be 17,8 million in 2008 and this number is growing. Recent improvements in cancer survival are largely due to earlier diagnosis and advancements in treatment. Despite having favorable effects on cancer survival, radiation therapy, surgery treatment and combination chemotherapy regimens can also cause longterm organ damage and functional disabilities. In this paper we review the most important aspects of long-term toxicities in otolaryngology cancer survivors patients.

Original languageEnglish
Pages (from-to)1473-1481
Number of pages9
JournalEuropean Review for Medical and Pharmacological Sciences
Volume18
Issue number10
Publication statusPublished - 2014

Fingerprint

Head and Neck Neoplasms
Survivors
Neoplasms
Therapeutics
Survival
Otolaryngology
Combination Drug Therapy
Early Diagnosis
Radiotherapy
Survival Rate

Keywords

  • Cancer
  • Chemotherapy
  • Head and neck cancer survivors
  • Radiation therapy
  • Survivors

ASJC Scopus subject areas

  • Medicine(all)
  • Pharmacology (medical)

Cite this

Head and neck cancer survivors patients and late effects related to oncologic treatment : Update of literature. / Taibi, R.; Lleshi, A.; Barzan, L.; Fiorica, F.; Leghissa, M.; Vaccher, E.; De Paoli, P.; Franchin, G.; Berretta, M.; Tirelli, U.

In: European Review for Medical and Pharmacological Sciences, Vol. 18, No. 10, 2014, p. 1473-1481.

Research output: Contribution to journalArticle

@article{7c3a073fe10e4052be48dd76f37dcc30,
title = "Head and neck cancer survivors patients and late effects related to oncologic treatment: Update of literature",
abstract = "Cancer survivorship represents a new challenge in the third Millennium. In Europe the number of cancer survivors was estimated to be 17,8 million in 2008 and this number is growing. Recent improvements in cancer survival are largely due to earlier diagnosis and advancements in treatment. Despite having favorable effects on cancer survival, radiation therapy, surgery treatment and combination chemotherapy regimens can also cause longterm organ damage and functional disabilities. In this paper we review the most important aspects of long-term toxicities in otolaryngology cancer survivors patients.",
keywords = "Cancer, Chemotherapy, Head and neck cancer survivors, Radiation therapy, Survivors",
author = "R. Taibi and A. Lleshi and L. Barzan and F. Fiorica and M. Leghissa and E. Vaccher and {De Paoli}, P. and G. Franchin and M. Berretta and U. Tirelli",
year = "2014",
language = "English",
volume = "18",
pages = "1473--1481",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "10",

}

TY - JOUR

T1 - Head and neck cancer survivors patients and late effects related to oncologic treatment

T2 - Update of literature

AU - Taibi, R.

AU - Lleshi, A.

AU - Barzan, L.

AU - Fiorica, F.

AU - Leghissa, M.

AU - Vaccher, E.

AU - De Paoli, P.

AU - Franchin, G.

AU - Berretta, M.

AU - Tirelli, U.

PY - 2014

Y1 - 2014

N2 - Cancer survivorship represents a new challenge in the third Millennium. In Europe the number of cancer survivors was estimated to be 17,8 million in 2008 and this number is growing. Recent improvements in cancer survival are largely due to earlier diagnosis and advancements in treatment. Despite having favorable effects on cancer survival, radiation therapy, surgery treatment and combination chemotherapy regimens can also cause longterm organ damage and functional disabilities. In this paper we review the most important aspects of long-term toxicities in otolaryngology cancer survivors patients.

AB - Cancer survivorship represents a new challenge in the third Millennium. In Europe the number of cancer survivors was estimated to be 17,8 million in 2008 and this number is growing. Recent improvements in cancer survival are largely due to earlier diagnosis and advancements in treatment. Despite having favorable effects on cancer survival, radiation therapy, surgery treatment and combination chemotherapy regimens can also cause longterm organ damage and functional disabilities. In this paper we review the most important aspects of long-term toxicities in otolaryngology cancer survivors patients.

KW - Cancer

KW - Chemotherapy

KW - Head and neck cancer survivors

KW - Radiation therapy

KW - Survivors

UR - http://www.scopus.com/inward/record.url?scp=84902209319&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84902209319&partnerID=8YFLogxK

M3 - Article

C2 - 24899605

AN - SCOPUS:84902209319

VL - 18

SP - 1473

EP - 1481

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 10

ER -